The 3rd LNP Immunogenicity and Toxicity Summit covers topics such as:
- Innovative Approaches to Immunogenicity Risk Assessment of mRNA-LNP Products to Unlock Therapeutic Potentials
- Bridging The Gap: Strengthening Translatability for Seamless Preclinical-to-Clinical Translation
- Advancing Clinical Safety for Enhanced Patient Safeguarding
- Afternoon Refreshments & Poster Session
- Enhancing Assessment of Immunogenicity & Toxicity for Safer Therapeutic Interventions
- Exploring the Structural Analysis of LNP & Its Impact on Immunogenicity for Amplified Therapeutic Potential
- Optimizing Therapeutic Safety: Unveiling the Impact of Diverse LNP Payloads on Immunogenicity & Toxicity
The 3rd LNP Immunogenicity and Toxicity Summit might be held in Boston, United States in Dec 2024.
